Trail Ridge Investment Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,943
Closed -$235K 105
2025
Q3
$235K Buy
+2,943
New +$251K 0.11% 102
2023
Q2
Sell
-8,685
Closed -$653K 116
2023
Q1
$653K Hold
8,685
0.43% 61
2022
Q4
$684K Hold
8,685
0.47% 62
2022
Q3
$648K Hold
8,685
0.43% 67
2022
Q2
$696K Buy
8,685
+200
+2% +$15.6K 0.47% 64
2022
Q1
$643K Hold
8,485
0.39% 72
2021
Q4
$724K Buy
+8,485
New +$663K 0.43% 66

Other funds holding CL

Trail Ridge Investment Advisors's CL Position: Q4 2025 in Review

Trail Ridge Investment Advisors sold out of Colgate-Palmolive (CL) in Q4 2025, closing a stake of 2,943 shares — an estimated $235K sold.

Trail Ridge Investment Advisors first reported a position in CL in Q4 2021 and held it in 7 quarters. The position peaked at $724K in Q4 2021. 1,892 funds tracked by Wall St. Rank hold CL as of Q4 2025.

  • Trail Ridge Investment Advisors reported no remaining Colgate-Palmolive position as of Q4 2025 after selling out during the quarter.
  • Trail Ridge Investment Advisors sold 2,943 Colgate-Palmolive shares in Q4 2025, an estimated $235K.
  • Trail Ridge Investment Advisors first reported a position in Colgate-Palmolive in Q4 2021 and held it in 7 quarters.
  • Trail Ridge Investment Advisors's Colgate-Palmolive position peaked at $724K in Q4 2021.
  • 1,892 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.

Based on Trail Ridge Investment Advisors's 13F filing for Q4 2025, filed 28 Jan 2026.